Chong Kun Dang Holdings made an additional purchase of Chong Kun Dang pharmaceutical equity. The combined equity stake of the largest shareholder and related parties neared 40%.
According to the Financial Supervisory Service's Data Analysis, Retrieval and Transfer System on Mar. 5, Chong Kun Dang pharmaceutical disclosed that the equity held by its largest shareholder, Chong Kun Dang Holdings, and six related parties was tallied at 39.93%, up 0.19 percentage point from the previous reporting date (Dec. 22, 2025). The number of shares held increased by 26,000, from 5,485,063 to 5,511,063.
The equity change was due to Chong Kun Dang Holdings' open-market purchase. From Feb. 27 to Mar. 6 over five trading days, Chong Kun Dang Holdings bought ▲ 5,000 shares on Feb. 27 ▲ 4,692 shares on Mar. 3 ▲ 4,308 shares on Mar. 4 ▲ 6,000 shares on Mar. 5 ▲ 6,000 shares on Mar. 6. As a result, Chong Kun Dang Holdings' equity ratio rose to 26.48%.